Trials / Completed
CompletedNCT03297372
Visual Performance Intraocular Lens (IOL) MicroPure 1.2.3.
Clinical Study to Investigate Visual Performance of Hydrophobic Monofocal IOL: MicroPure 1.2.3.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 121 (actual)
- Sponsor
- Beaver-Visitec International, Inc. · Industry
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
The clinical investigation is a post-market clinical follow up study whereby patients undergoing routine cataract surgery will have monolateral implantation of a commercially available, CE approved monofocal intraocular lens MicroPure 1.2.3. (PhysIOL, Liège, Belgium).
Detailed description
The examinations consist of visual acuity data, contrast sensitivity exams, slitlamp examinations and posterior capsule opacification (PCO) grading. Follow up will be up to 24 months postoperative.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | IOL implantation | Implantation of monofocal IOL Micropure 1.2.3 |
Timeline
- Start date
- 2017-10-23
- Primary completion
- 2022-09-08
- Completion
- 2022-09-08
- First posted
- 2017-09-29
- Last updated
- 2022-10-28
Locations
2 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT03297372. Inclusion in this directory is not an endorsement.